ClinicalTrials.govpublic full text
Phase I Study of OSI-930 and Erlotinib in Cancer Tumors
advanced solid tumors, gist, ovarian cancer, mesothelioma, renal, colorectal cancer, sarcoma, nsclc, cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 909544
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.